FLAGYL 4 % oral suspension AVENTIS
Active substance: metronidazole
J01XD01 Antiinfectives for systemic use | Other antibacterials | Imidazole derivatives
Indicated for: bacterial and protozoal infections
Find medicines for human use by name or active substance.
Browse by initial
381–400 of 836 medicines
Active substance: metronidazole
J01XD01 Antiinfectives for systemic use | Other antibacterials | Imidazole derivatives
Indicated for: bacterial and protozoal infections
Active substance: metronidazole
Indicated for: bacterial and protozoal infections
Active substance: pyroxycam
Indicated for: pain and inflammation
Active substance: pyroxycam
Indicated for: pain and inflammation
Active substance: silver sulfadiazine + cerium nitrate
D06BA51 Dermatologicals | Chemotherapeutics for topical use | Sulfonamides
Indicated for: angina pectoris
Active substance: sulfadiazine
D06BA01 Dermatologicals | Chemotherapeutics for topical use | Sulfonamides
Indicated for: bacterial infections
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: plants
R02AA20 Respiratory system | Throat preparations | Throat preparations | Antiseptics
Indicated for: herbal symptomatic treatment
Active substance: Ginkgo biloba
Indicated for: cognitive disorders; peripheral vascular disease
Active substance: Ginkgo biloba
Indicated for: cognitive disorders; peripheral vascular disease
Active substance: Ginkgo biloba
Indicated for: cognitive disorders; peripheral vascular disease
Active substance: diosmin
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: diosmin
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.